Pure Global
NCT06245200

UNIPDES- An Internet-Based Transdiagnostic Intervention for College Students' Psychological Symptoms

UNIPDES- An Internet-Based Transdiagnostic Intervention for College Students' Psychological Symptoms: Evaluation of Its Development, Usability and Effectiveness Study Protocol
Anadolu University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Mental Health Issue
Drug/Device/Intervention
UNIPDES - Internet Based Intervention - GUIDED
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Anadolu University
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Aug 25, 2025
Enrollment
330 participants
Primary outcome

Patient Health Questionnaire-9 (PHQ-9) Turkish Form,Generalized Anxiety Disorder-7 (GAD-7) Turkish Form,The Brief Adjustment Scale-6 (BASE-6) Turkish Form

Summary

This study is a randomised clinical trial. This study evaluates the effect of an
 internet-based intervention developed based on a transdiagnostic cognitive behavioural
 approach on psychological symptoms of university students. There are internet-based guided
 intervention, internet-based unguided intervention and control group in the study.
 
 Experimental group participants (guided and unguided) will use the UNIPDES programme
 developed within the scope of the project. Participants in the guided internet-based
 experimental group will additionally receive weekly feedback from the guide .

ICD-10 classifications
Mental disorder, not otherwise specifiedMental and behavioural disordersUnspecified mental disorderProblems related to certain psychosocial circumstancesProblems related to other psychosocial circumstances
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06245200
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06245200 through Pure Global AI's free database. This phase not specified trial is sponsored by Anadolu University and is currently Not yet recruiting. The study focuses on Mental Health Issue. Target enrollment is 330 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.